Tumour extracellular vesicles induce neutrophil extracellular traps to promote lymph node metastasis

Abstract Lymph nodes (LNs) are frequently the first sites of metastasis. Currently, the only prognostic LN assessment is determining metastatic status. However, there is evidence suggesting that LN metastasis is facilitated by the formation of a pre‐metastatic niche induced by tumour derived extrace...

Full description

Bibliographic Details
Main Authors: Xin Su, Ariane Brassard, Alexandra Bartolomucci, Iqraa Dhoparee‐Doomah, Qian Qiu, Thupten Tsering, Ramin Rohanizadeh, Olivia Koufos, Betty Giannias, France Bourdeau, Lixuan Feng, Julia Messina‐Pacheco, Sabrina Leo, Veena Sangwan, Daniela Quail, James Tankel, Jonathan Spicer, Julia Valdemarin Burnier, Swneke Donovan Bailey, Lorenzo Ferri, Jonathan Cools‐Lartigue
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:Journal of Extracellular Vesicles
Subjects:
Online Access:https://doi.org/10.1002/jev2.12341
Description
Summary:Abstract Lymph nodes (LNs) are frequently the first sites of metastasis. Currently, the only prognostic LN assessment is determining metastatic status. However, there is evidence suggesting that LN metastasis is facilitated by the formation of a pre‐metastatic niche induced by tumour derived extracellular vehicles (EVs). Therefore, it is important to detect and modify the LN environmental changes. Earlier work has demonstrated that neutrophil extracellular traps (NETs) can sequester and promote distant metastasis. Here, we first confirmed that LN NETs are associated with reduced patient survival. Next, we demonstrated that NETs deposition precedes LN metastasis and NETs inhibition diminishes LN metastases in animal models. Furthermore, we discovered that EVs are essential to the formation of LN NETs. Finally, we showed that lymphatic endothelial cells secrete CXCL8/2 in response to EVs inducing NETs formation and the promotion of LN metastasis. Our findings reveal the role of EV‐induced NETs in LN metastasis and provide potential immunotherapeutic vulnerabilities that may occur early in the metastatic cascade.
ISSN:2001-3078